发明名称 PHARMACEUTICAL COMPOSITION PIPERIDYLAMINOMETHYLTRIFLUOROMETHYL CYCLIC ETHER COMPOUND AS SUBSTANCE P ANTAGONIST
摘要 PROBLEM TO BE SOLVED: To provide a substance P antagonist improved in activity and further reduced in adverse effect. SOLUTION: The invention relates to a pharmaceutical composition comprising a compound represented by the formula (1) [R<1> is a 1-6C alkyl; R<2> is hydrogen, a 1-6C alkyl, a halo-1-6C alkyl or phenyl; R<3> is hydrogen or a halogen; R<4> and R<5> are independently hydrogen, a 1-6C alkyl or a halo-1-6C alkyl; n is 1, 2 or 3] and a pharmaceutically acceptable salt thereof and useful as a analgesic or antiinflammatory agent or useful in treatment of diseases, disorder or harmful state caused by cardiovascular diseases, allergic diseases, angiogenesis, CNS disorder, vomiting, gastrointestinal injury, solar dermatitis, urinary incontinence or Helicobacter pylori in mammal, particularly human.
申请公布号 JP2003040777(A) 申请公布日期 2003.02.13
申请号 JP20020177452 申请日期 2002.06.18
申请人 PFIZER PHARMACEUTICALS INC 发明人 SATAKE KUNIO
分类号 A61K;A61K31/443;A61K31/445;A61K31/4453;A61K31/452;A61K31/4523;A61K31/4525;A61K31/453;A61P1/00;A61P1/04;A61P1/08;A61P9/00;A61P9/10;A61P11/00;A61P11/06;A61P13/00;A61P13/02;A61P15/00;A61P15/10;A61P17/00;A61P17/02;A61P19/02;A61P25/00;A61P25/04;A61P25/06;A61P25/18;A61P25/22;A61P25/24;A61P25/28;A61P29/00;A61P31/04;A61P37/00;A61P37/08;A61P43/00;C07D;C07D211/06;C07D211/56;C07D295/00;C07D307/78;C07D307/87;C07D311/76;C07D405/12;(IPC1-7):A61K31/452 主分类号 A61K
代理机构 代理人
主权项
地址